Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 6 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 4 days agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 5 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Buckingham Capital Management Inc. Sells 94 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 hours agoBuckingham Capital Management Inc. cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.1% during the 1st quarter, Holdings Channel.com reports. The institutional investor ...
Red Spruce Capital LLC Acquires 62 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 hours agoRed Spruce Capital LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 49,680 shares of the company ...
First Financial Bank Trust Division Has $345,000 Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoFirst Financial Bank Trust Division lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.2% during the first quarter, according to the company in its most recent Form 13F filing ...
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a...
Insider Monkey via Yahoo Finance· 1 day agoWe recently compiled a list of the 10 Best Robinhood Stocks Under $20. In this article, we are going...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 4 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
M&R Capital Management Inc. Has $2.84 Million Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoM&R Capital Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent filing with the Securities ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 4 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...